Journal article
Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)1
Abstract
Background: Fourth-line therapy (4LT) in the treatment of metastatic renal cell carcinoma (mRCC) varies significantly due to the lack of data and recommendations to guide treatment decisions. Objective: To evaluate the use and efficacy of 4LT in mRCC patients. Methods: The International mRCC Database Consortium (IMDC) dataset was used to identify patients with mRCC treated with 4LT. This is a multicenter, retrospective cohort study. Overall …
Authors
Stukalin I; Wells JC; Fraccon A; Pasini F; Porta C; Lalani A-KA; Srinivas S; Bowman IA; Brugarolas J; Lee J-L
Journal
Kidney Cancer, Vol. 2, No. 1, pp. 31–36
Publisher
SAGE Publications
Publication Date
March 30, 2018
DOI
10.3233/kca-170020
ISSN
2468-4562